FDA rejects Immunomedics breast cancer drug, extending long regulatory drought
ANDREW HARNIK/AP
The 37-year drug development drought lives on.
Sols 4345-4347: Contact Science is Back on the Table
Hace 20 horas
Suscribirse a:
Enviar comentarios (Atom)
.jpeg)
No hay comentarios:
Publicar un comentario